Global Med Technologies(R), Inc. Signs Nationwide Contract With Nigeria

Global Med Technologies(R), Inc. Signs Nationwide Contract With Nigeria Global Med to Install SafeTrace(R) and SafeTrace Tx(R)* Throughout Nigeria DENVER, June 29 /PRNewswire-FirstCall/ -- Wyndgate Technologies(R) ("Wyndgate"), a division of Global Med Technologies(R), Inc. (OTC:GLOB) (BULLETIN BOARD: GLOB) ("Global Med" or the "Company"), announced the signing of a nationwide contract with Nigeria for its SafeTrace(R) donor management system and SafeTrace Tx(R) advanced transfusion management system. Nigeria is the largest country by population in Africa, with approximately 130 million people. Terms of the contract were not disclosed. (Logo: http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) Global Med will be working very closely with Safe Blood for Africa(TM) Foundation ("SBFA") as SBFA establishes, upgrades and operates the Nigeria National Blood Transfusion Service in collaboration with the Federal Ministry of Health. The agreement will provide for the installation of Global Med's blood bank information systems in each blood center operated by Safe Blood for Africa Foundation. Stephen Field, M.D., Medical Director for Safe Blood for Africa Foundation, said, "Blood centers in underdeveloped countries face challenges beyond those in technologically-advanced countries. Blood shortages are a concern and the blood supply is at risk of possible contamination with blood- borne diseases, such as HIV, hepatitis, syphilis, etc." Dr. Field continued, "Replacing Nigeria's blood centers' manual processes and manual records with automated solutions can help to manage Nigeria's donor testing and help to ensure the safe release of blood and blood products for transfusion. About six additional centers are interested in installing Global Med Technologies this year alone. Global Med was our first choice in world-wide blood donor and hospital transfusion information systems." Will Willman, Senior Vice President of International Business Development, stated, "Based on the success of the installation of SafeTrace in Abuja, Nigeria, many other centers in Nigeria were very eager for a similar information system solution. The use of readily available satellite technology enables a robust solution in the technologically challenged African environment." Mr. Willman added, "This nationwide contract and implementation of Global Med's donor and hospital transfusion systems via satellite throughout the country of Nigeria is an indication of Global Med's ability to provide its software to entire countries, not only in Africa, but throughout the world. In addition, the quality of our products and the competency of our employees provide the foundation for future installations in international markets. The international market affords a $500+ million dollar opportunity for Global Med." About Global Med Technologies, Inc. Global Med Technologies, Inc. is an international e-Health, medical information technology company, providing information management software products and services to the healthcare industry. Its Wyndgate Technologies division is a leading supplier of information management systems to U.S. and international blood centers and hospital transfusion centers. Current clients of Wyndgate's products and services manage more than 3 million units of blood, or over 22% of the U.S. blood supply, each year. Wyndgate's products are also being implemented in Canada, the Caribbean and sub-Saharan Africa. Together, the SafeTrace donor management system and the SafeTrace Tx(R)* advanced transfusion management system provide Vein-to-Vein(R) tracking from donor collection to patient transfusion. For more information about Global Med's products and services, please call 800-WYNDGATE or visit http://www.globalmedtech.com/, http://www.peoplemed.com/ and http://www.wyndgate.com/. This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release. *Patent Pending http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies, Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies(R), Inc., +1-303-238-2000; or investor relations, John Nesbett, or Jordan Silverstein, both of The Investor Relations Group, +1-212-825-3210, for Global Med Technologies, Inc. Web site: http://www.globalmedtech.com/ http://www.peoplemed.com/ http://www.wyndgate.com/